Abstract:Muscleblind-like proteins (MBNLs) are a family of RNA-binding proteins that play essential roles in the regulation of RNA metabolism. Beyond their canonical role in RNA regulation, MBNL proteins have emerged as key players in the pathogenesis of Myotonic Dystrophy type 1 (DM1). In DM1, sequestration of MBNL proteins by expansion of the CUG repeat RNA leads to functional depletion of MBNL, resulting in deregulated alternative splicing and aberrant RNA processing, which underlie the clinical features of the disease. While attention to MBNL proteins has focused on their functions in skeletal muscle, new evidence suggests that their importance extends to motor neurons (MNs), pivotal cellular components in the control of motor skills and movement. To address this question, we generated conditional double knockout mice in which Mbnl1 and Mbnl2 were specifically deleted in motor neurons (MN-dKO). Adult MN-dKO mice develop gait coordination deficits associated with structural and ultrastructural defects in the neuromuscular junction, indicating that MBNL activity in MNs is crucial for the maintenance of the neuromuscular junction. In addition, transcriptome analysis performed on the spinal cord of MN-dKO mice identified mis-splicing events in genes associated with synaptic transmission and neuromuscular junction homeostasis. In summary, our results highlight the complex roles and regulatory mechanisms of MBNL proteins in MNs for muscle function and locomotion. This work provides valuable insights into fundamental aspects of RNA biology and offers promising avenues for therapeutic intervention in DM1 as well as a range of diseases associated with RNA dysregulation.

CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1

Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats

The Rna-Binding Protein Cugbp1 Regulates Stability of Tumor Necrosis Factor Mrna in Muscle Cells - Implications for Myotonic Dystrophy

Phase-separated stress granules and processing bodies are compromised in Myotonic Dystrophy Type 1

MBNL splicing factors regulate the microtranscriptome of skeletal muscles

MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model

Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration

Identification of ZNF850 as a novel CTG repeat expansion-related gene in myotonic dystrophy type 1 patient-derived iPSCs

Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy

Celf1 Regulates Cell Cycle and is Partially Responsible for Defective Myoblast Differentiation in Myotonic Dystrophy RNA Toxicity.

Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats

Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1

Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy

A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways

Aberrant Myokine Signaling in Congenital Myotonic Dystrophy

Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy